Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: Initial results

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 185, Issue 11, 2013, Pages 1056-1062

  Heusch, P ^a,b   Buchbender, C ^a,b   Kohler J ^a,c   Nensa, F ^a   Beiderwellen, K ^a   Kuhl H ^a   Lanzman, R S ^a,b   Wittsack, H J ^a,b   Gomez, B ^a   Gauler, T ^a,c   Schuler, M ^a,c   Forsting, M ^a   Bockisch, A ^a   Antoch, G ^a,b   Heusner, T A ^a,b  

^a Department of Diagnostic and Interventional Radiology ^*  (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

MR diffusion perfusion; PET CT; thorax

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; FEMALE; HEALTH CARE; HISTOPATHOLOGY; HUMAN; LUNG LESION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PET SCANNER; PRIMARY TUMOR; PRIORITY JOURNAL; WHOLE BODY MRI; WHOLE BODY PET;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MULTIMODAL IMAGING; OBSERVER VARIATION; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 84886597118     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0033-1350110     Document Type: Article

References (40)

1. Jemal A., Bray F., Center M. M. et al. Global cancer statistics. CA: a cancer journal for clinicians: 2011; 61 69 90
2. Antoch G., Stattaus J., Nemat A. T. et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology: 2003; 229 526 533 (Pubitemid 37310842)
3. Cerfolio R. J., Bryant A. S., Ohja B. et al. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg: 2005; 130 151 159 (Pubitemid 40941684)
4. Regier M., Kandel S., Kaul M. G. et al. Detection of small pulmonary nodules in high-field MR at 3 T: evaluation of different pulse sequences using porcine lung explants. Euro Radiol: 2007; 17 1341 1351 (Pubitemid 46691965)
5. Heusner T. A., Kuemmel S., Koeninger A. et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging: 2010; 37 1077 1086
6. Wu L. M., Gu H. Y., Zheng J. et al. Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis. Journal of magnetic resonance imaging: J Magn Reson Imaging: 2011; 34 128 135
7. Eiber M., Holzapfel K., Ganter C. et al. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI. J Magn Reson Imaging: 2011; 33 1160 1170
8. Kim J. K., Kim K. A., Park B. W. et al. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging: 2008; 28 714 719
9. Liu Y., Liu H., Bai X. et al. Differentiation of metastatic from non-metastatic lymph nodes in patients with uterine cervical cancer using diffusion-weighted imaging. Gynecol Oncol: 2011; 122 19 24
10. Razek A. A. Diffusion magnetic resonance imaging of chest tumors. Cancer imaging: the official publication of the International Cancer Imaging Society: 2012; 12 452 463
11. Matoba M., Tonami H., Kondou T. et al. Lung carcinoma: diffusion-weighted mr imaging - preliminary evaluation with apparent diffusion coefficient. Radiology: 2007; 243 570 577 (Pubitemid 46649714)
12. Buchbender C., Heusner T. A., Lauenstein T. C. et al. Oncologic PET/MRI, Part 2: Bone Tumors, Soft-Tissue Tumors, Melanoma, and Lymphoma. J Nucl Med: 2012; 53 1244.52 6
13. Herzog H., Van Den Hoff J. Combined PET/MR systems: an overview and comparison of currently available options. Q J Nucl Med Mol Imaging: 2012; 56 247 267
14. Antoch G., Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging: 2009; 36 01 S113 S120
15. Drzezga A., Souvatzoglou M., Eiber M. et al. First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses. J Nucl Med: 2012; 53 845 855
16. Schwenzer N. F., Schraml C., Muller M. et al. Pulmonary Lesion Assessment: Comparison of Whole-Body Hybrid MR/PET and PET/CT Imaging - Pilot Study. Radiology: 2012; 264 551 558
17. Schwenzer N. F., Pfannenberg C., Reischl G. et al. [Application of MR/PET in oncologic imaging]. Fortschr Röntgenstr: 2012; 184 780 787
18. Regier M., Derlin T., Schwarz D. et al. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)? Euro J Radiol: 2012; 81 2913 2918
19. Buchbender C., Hartung-Knemeyer V., Heusch P. et al. Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system? Eur J Radiol: 2013; 82 380 4
20. Marom E. M., Munden R. F., Truong M. T. et al. Interobserver and intraobserver variability of standardized uptake value measurements in non-small-cell lung cancer. J Thorac Imaging: 2006; 21 205 212 (Pubitemid 44258947)
21. Heusch P., Buchbender C., Beiderwellen K. et al. Standardized uptake values for [(18)F] FDG in normal organ tissues: Comparison of whole-body PET/CT and PET/MRI. Eur J Radiol: 2013; 82 870 876
22. Wiesmüller M., Quick H. H., Navalpakkam B. et al. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging: 2013; 40 12 21
23. Kligerman S., Digumarthy S. Staging of non-small cell lung cancer using integrated PET/CT. Am J Roentgenol: 2009; 193 1203 1211
24. Higashi K., Ueda Y., Arisaka Y. et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. J Nucl Med: 2002; 43 39 45 (Pubitemid 34101186)
25. Weber W. A., Petersen V., Schmidt B. et al. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol: 2003; 21 2651 2657 (Pubitemid 46606307)
26. Huang W., Zhou T., Ma L. et al. Standard uptake value and metabolic tumor volume of (1)(8)F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging: 2011; 38 1628 1635
27. Ohno Y., Koyama H., Yoshikawa T. et al. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. Am J Roentgenol: 2012; 198 75 82
28. Wu X., Korkola P., Pertovaara H. et al. No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET/CT and DW-MRI study. Euro J Radioly: 2011; 79 e117 e121
29. Choi B. B., Kim S. H., Kang B. J. et al. Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma. World J Surg Oncol: 2012; 10 126
30. Wong C. S., Gong N., Chu Y. C. et al. Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV. Euro J Radiol: 2012; 81 2122 2126
31. Gu J., Khong P. L., Wang S. et al. Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT. Mol Imaging Biol: 2011; 13 1020 1028
32. Nakajo M., Nakajo M., Kajiya Y. et al. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient. Clin Nucl Med: 2012; 37 475 480
33. Dale B. M., Braithwaite A. C., Boll D. T. et al. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging of the abdomen. Invest Radiol: 2010; 45 104 108
34. Padhani A. R., Liu G., Koh D. M. et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia: 2009; 11 102 125
35. Kuhnke M., Langner S., Khaw A. V. et al. Diffusionsgewichtete MRT- wie viele Diffusionsfaktoren sind notwendig? Fortschr Röntgenstr: 2012; 184 303 310
36. Heusch P., Wittsack H. J., Kröpil P. et al. Impact of blood flow on diffusion coefficients of the human kidney: a time-resolved ECG-triggered diffusion-tensor imaging (DTI) study at 3T. J Magn Reson Imaging: 2013; 37 233 236
37. Rao R. K., Riffel P., Meyer M. et al. Implementation of dual-source RF excitation in 3 T MR-scanners allows for nearly identical ADC values compared to 1.5 T MR scanners in the abdomen. PloS one: 2012; 7 e32613
38. Heijmen L., Ter Voert EE, Nagtegaal I. D. et al. Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation. Eur Radiol: 2013; 23 748 756
39. Thoeny H. C., Zumstein D., Simon-Zoula S. et al. Functional evaluation of transplanted kidneys with diffusion-weighted and BOLD MR imaging: initial experience. Radiology: 2006; 241 812 821 (Pubitemid 46190548)
40. Malyarenko D., Galbán C. J., Londy F. J. et al. Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom. J Magn Reson Imaging: 2013; 37 1238 1246